Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001104659-14-080993

10% owner acquired 2,499,499 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KKR Biosimilar L.P. 10% owner 2014-11-12 Conversion +2,499,499 2,499,499 I
Derivatives
KKR Biosimilar L.P. 10% owner 2014-11-12 Conversion · Series C Preferred Stock −2,499,499 0 I
Loading xslF345X03/a4.xml…